Jennifer Colombo

Dr. Jennifer Colombo

Children's Mercy Kansas City
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Medicine
Verified
Journal Article
Open access
JCJennifer Colombo
Jennifer Colombo
ADAmanda D Deacy
Amanda D Deacy
JSJennifer V Schurman
Jennifer V Schurman
CFCraig A Friesen
Craig A Friesen
The aim of this study was to assess the relationship of heartburn in pediatric patients with functional dyspepsia (FD) and irritable bowel syndrome (IBS) with gastrointestinal symptoms, sleep disturbances, and psychologic distress. The overlap in symptoms of FD, IBS, and gastroesophageal reflux disease (GERD) predicts greater symptom severity and decreased quality of life and presents opportunities for improved diagnostic classification and personalized therapeutics.A cross-sectional observational study of 260 pediatric patients with abdominal pain was conducted. Patients completed standardized questionnaires assessing clinical symptoms, sleep quality, and psychologic symptoms during routine clinical care. Questionnaire data were compared for patients reporting heartburn and not reporting heartburn using χ 2 and t tests where appropriate. Gastrointestinal symptoms were significantly more prevalent among patients with a positive report of heartburn (vs a negative report of heartburn): pain with eating (83% vs 67%, P = .007), bloating (63% vs 44%, P = .005), acid regurgitation (47% vs 24%, P ≤ .001), and chest pain (45% vs 20%, P ≤ .001). Likewise, initiating and maintaining sleep (P = .007), arousal/nightmares (P = .046), sleep-wake transition (P = .001), hyperhidrosis during sleep (P = .016), and anxiety (P = .001) and depression (P = .0018) were also significantly increased in patients who reported heartburn versus patients who did not report heartburn. Patients with a positive report of heartburn, whether classified as having FD and/or IBS, had increased gastrointestinal symptoms, sleep disturbances, anxiety, and depression than patients with a negative report of heartburn. A better understanding of these associations may allow for personalized treatment for youth with abdominal pain and heartburn as a primary symptom.

1 November 2021 in Children
Verified
Journal Article
Open access
PDF file
MLMichelle Livitz
Michelle Livitz
AFAlec S. Friesen
Alec S. Friesen
EGEarl F. Glynn
Earl F. Glynn
JSJennifer Schurman
Jennifer Schurman
JCJennifer Colombo
Jennifer Colombo
Craig A. FriesenCraig A. Friesen
Craig A. Friesen
The purpose of this study was to assess cost variability in the care of abdominal pain-associated functional gastrointestinal disorders (AP-FGIDS) in youth across health systems, races, and specific AP-FGID diagnoses. Patients, aged 8–17 years, with a priority 1 diagnosis corresponding to a Rome IV defined AP-FGID were identified within the Health Facts® database. Total costs were obtained across the continuum of care including outpatient clinics, emergency department, and inpatient or observation units. Cost variability was described comparing different health systems, races, and diagnoses. Thirteen thousand two hundred and fourteen patients were identified accounting for 17,287 encounters. Total costs were available for 38.7% of the encounters. There was considerable variability in costs within and, especially, across health systems. Costs also varied across race, urban vs. rural site of care, and AP-FGID diagnoses. In conclusion, there was considerable variability in the costs for care of AP-FGIDs which is sufficient to support multi-site studies to understand the value of specific tests and treatments. Significant differences in costs by race merit further investigation to understand key drivers.

9 January 2019 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
Craig A. FriesenCraig A. Friesen
Craig A. Friesen
JCJennifer Colombo
Jennifer Colombo
JSJennifer Schurman
Jennifer Schurman
Although not required to establish the diagnosis, endoscopy with mucosal biopsy is commonly performed in the evaluation of children with dyspepsia. Traditionally, esophagogastroduodenoscopy (EGD) has been performed in children with abdominal pain to identify pathology or conversely, to “rule-out” organic disease in order to establish a diagnosis of FD. In this review, we discuss the current diagnostic yield of endoscopically-obtained biopsies in identifying disease in children and adolescents with dyspepsia including an expanded discussion of common histologic diagnoses where clinical significance has not been definitively established. In turn, we discuss the transition of endoscopy from a search for disease to a search for biologic contributors to symptom generation, while considering the growing evidence linking non-diagnostic mucosal inflammation to FD, specifically mast cells and eosinophils.

16 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Craig A. FriesenCraig A. Friesen
Craig A. Friesen
JCJennifer Colombo
Jennifer Colombo
JSJennifer Schurman
Jennifer Schurman
Both functional abdominal pain disorders (FAPDs) and food allergies are relatively common in children and adolescents, and most studies report an association between FAPDs and allergic conditions. FAPDs share pathophysiologic processes with allergies, including both immune and psychological processes interacting with the microbiome. No conclusive data are implicating IgE-mediated reactions to foods in FAPDs; however, there may be patients who have IgE reactions localized to the gastrointestinal mucosa without systemic symptoms that are not identified by common tests. In FAPDs, the data appears stronger for aeroallergens than for foods. It also remains possible that food antigens initiate an IgG reaction that promotes mast cell activation. If a food allergen is identified, the management involves eliminating the specific food from the diet. In the absence of systemic allergic symptoms or oral allergy syndrome, it appears unlikely that allergic triggers for FAPDs can be reliably identified by standard testing. Medications used to blunt allergic reactions or symptomatically treat allergic reactions may be useful in FAPDs. The purpose of the current manuscript is to review the current literature regarding the role of allergy in FAPDs from a clinical perspective, including how allergy may fit in the current model of FAPDs.

1 March 2025 in Pediatric Health, Medicine and Therapeutics
Verified
Journal Article
Open access
PDF file
HFHunter J Friesen
Hunter J Friesen
NSNeha Singh
Neha Singh
JSJennifer V Schurman
Jennifer V Schurman
ADAmanda D Deacy
Amanda D Deacy
CFCraig Friesen
Craig Friesen
JCJennifer Colombo
Jennifer Colombo
Objective/Purpose/Aim: Sleep disturbances have been implicated as contributors to chronic pain. We undertook this review to assess the current literature regarding sleep disturbances in youth with chronic abdominal pain. We assessed studies evaluating prevalence, pathophysiology, and/or outcomes to identify gaps in knowledge and to determine whether there is an evidential basis for sleep interventions in this population. Materials and Methods: Utilizing Google Scholar, Pub Med, SCOPUS, and Embase, we searched using the terms “sleep disturbances” AND (“abdominal pain”/exp OR “abdominal pain”) AND ([adolescent]/lim OR [school]/lim). Articles were included if they contained data regarding sleep disturbance prevalence, pathophysiology, or relationships to outcome. After two independent review, 32 manuscripts were included in this review. Results: Based on their high prevalence (19– 75% of abdominal pain cohorts), there is sufficient evidence to recommend routine screening for sleep disturbances in youth with chronic abdominal pain. There is a broad range of negative physiologic and emotional effects of sleep deprivation. Conclusion: Sleep disturbances are common in youth with chronic abdominal pain. Sleep interventions are appropriate when disturbances are identified though it is not yet known the degree to which these interventions will affect the pain experience and resultant disability. Future studies should focus on evaluation of specific sleep interventions on patient outcomes.

1 January 2013 in World Journal of Gastrointestinal Pharmacology and Therapeutics
Verified
Journal Article
Open access
JCJennifer Colombo
Jennifer Colombo
NNNancy A Neilan
Nancy A Neilan
JSJennifer Verrill Schurman
Jennifer Verrill Schurman
CFCraig A Friesen
Craig A Friesen
Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophilia